EUROPE E-PRESCRIBING MARKET SIZE TO CROSS USD 1 BILLION BY 2026, GROWING AT A CAGR OF 23% DURING THE FORECAST PERIOD

Europe E-Prescribing Market Size, Share, Trends Analysis Report by Type (Standard E-prescribing and Electronic Prescribing for Controlled Substances (EPCS)); Delivery Mode (Web & Cloud-based and On-premise & Desktop); Modality (Integrated and Standalone), Medication Type (Cardiovascular, Anti-Infectives, Oncology, Pain Management, Behavioral & Mental health, and Others); End-User (Technology Vendors, Independent & Specialty Pharmacies, Healthcare Facilities, and Pharmacy Benefit Management (PBM) & Payors); and Geography (Europe); Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2026

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

220 Pages

icon-table

25 Tables

icon-chart

105 Charts

icon-region

1 Regions

icon-country

11 Countries

icon-company

11 Companies

icon-market

6 Market Segment

EUROPE E-PRESCRIBING MARKET REPORT SCOPE

Report Attribute Details
Market Size (Revenue) USD 1 BILLION (2026)
CAGR 23% (2021-2026)
Base Year 2020
Forecast Year 2021 –2026
Market Segments Type (Standard and Electronic Prescribing for Controlled Substances (EPCS)), Delivery Mode (Web & Cloud-based and On-premise & Desktop), Modality (Integrated and Standalone), Medication Type (Cardiovascular, Anti-Infectives, Oncology, Pain Management, Behavioral & Mental health, and Others), End-User (Technology Vendors, Independent & Specialty Pharmacies, Healthcare Facilities, and Pharmacy Benefit Management (PBM) & Payors)
Geographic Analysis Europe
Countries Covered UK, Italy, Spain, Germany, France, Netherlands, Sweden, Denmark, Austria, Finland, and Others

EUROPE E-PRESCRIBING INDUSTRY INSIGHTS

 The Europe e-prescribing market to cross over USD 1 billion, growing at a CAGR of around 23% during the forecast period.

Telehealth services are among the second biggest eHealth trends in Europe after patient electronic health records. One of the significant factors driving the industry growth is the growing awareness and acceptance of remote monitoring solutions and increasing technological advances. For example, in March 2020, Germany performed more than 19,500 teleconsultations. In Norway, the share of e-consultations was almost 60%. France is a successful example of telehealth adoption, with nearly ten years of successful telehealth legislation in place.  Artificial intelligence to transform the digital prescription technology market in Europe. Big data analytics and machine learning algorithms for analyzing large-scale EMRs data are developed to understand the way prescribers treat patients automatically in real-life scenarios. For instance, AI helps prevent drug overdose by utilizing the medication history to predict the potential for opioid overdose priorly, augmenting the efforts of clinicians to detect such life-threatening risks. 

E-prescription to compliment cross-border healthcare across Europe. 

An eHealth Digital Service Infrastructure (eHDSI) was developed to ensure the continuity of care for European citizens traveling abroad in the EU. The eHDSI is giving EU countries the opportunity to exchange health data in an efficient, secure, and interoperable manner. E-prescribing in independent and specialty pharmacies is gaining immense traction. Independent and specialty pharmacies accounted for around 13% of the Europe e-prescribing market share in 2020. 

SNIPPETS 

  • Privacy and security issues are some of the major concerns in the e-prescribing process.
  • The Europe e-prescribing market by healthcare facilities to reach around USD 139 million by 2026.
  • The incremental growth rate of EPCS is projected around USD 62 million during the forecast period.
  • Europe web and cloud-based e-prescription accounted for a significant share and is likely to witness an absolute growth of over 256% during the forecast period.
  • Anti-infective, cardiovascular & others are the top 3 contributors in terms of incremental growth in the end-users segment.
  • E-prescription technology vendors accounted for a share of over 72% in the e-prescribing market in Europe in 2020.
  • EU-5 is likely to witness absolute growth of over 252% during the forecast period. 

EUROPE E-PRESCRIBING MARKET SEGMENTATION 

The Europe e-prescribing market research report includes detailed segmentation by 

  • Type
  • Delivery Model
  • Modality
  • Medication type
  • End-user

 INSIGHTS BY TYPE  

The standard e-prescribing segment to grow at a CAGR of around 23% by 2026.

The standard segment accounted for a share of over 94% in the Europe e-prescribing market in 2020. Standard e-prescribing system is a robust technology facilitating an interactive data transaction. These transactions in standard software allow prescribers to view a complete medication list of patients. E-prescribing enhances the efficiency and effectiveness of patient care through automated clinical decision support and tracking of complete medication profiles. Such tools can reduce patient risk towards drugs by identifying them automatically.  

The use of EPCS can potentially reduce prescription drug abuse. It has produced new identity proofing responsibilities for EHR vendors, providers, and prescribers through two-factor authentication, strict auditing methods, and more robust audit trails. EPCS can significantly reduce the burden on patients by avoiding multiple visits between pharmacies and providers for prescriptions or otherwise in need of treatment with controlled substances. Several healthcare providers are likely to adopt EPCS to stay in compliance and improve their prescribing processes. 

INSIGHTS BY DELIVERY MODEL 

Web & cloud-based e-prescription market to witness an incremental growth of over USD 640 million.

Cloud and web-based systems are highly preferred than on-premise as it does not require complex installation processes to set up intense infrastructure to host data. One of the major reasons for the high adoption of web-based solutions is that it can be done through the internet without IT support and minimizes additional costs. Cloud services enable the ability to access healthcare data from different locations and across multiple devices. It can access and process EHRs, collect data, and visualize diagnostic images in various resolutions. 

INSIGHTS BY MODALITY 

The integrated modality segment is likely to grow at the highest CAGR during the forecast period. 

The integrated e-prescribing solutions are in high demand and accounting for a significant share of over 88% in the modality segment. Integrated solutions can improve patient safety and communication with providers. It provides real-time, patient-centered records that are instant, secure, and accessible only by authorized users at a medical practice and provide a broad view of the care a patient has received. Vendors are increasingly focusing on adopting the integration of EHR into their e-prescribing solutions. Emerging players are offering integrated services, which is contributing to its wider acceptance. 

INSIGHTS BY MEDICATION TYPE 

Cardiovascular accounted for the second largest industry share in the European e-prescribing market.   

Cardiovascular drugs are the most commonly e-prescribing medications mainly due to the fact of the increasing prevalence of cardiovascular diseases. These remain the leading cause of mortality and a significant cause of morbidity in Europe, causing 45% of all deaths in Europe and 37% in the European Union. The medication type segment includes cardiovascular, anti-infectives, oncology, pain management, behavioral and mental health, and others. With the growing burden of various diseases, the consumption of drugs has drastically increased. E-prescription has emerged as an effective solution to control the overuse of medications and prevent adverse drug events associated with their overdose. It has successfully proven to reduce such adverse events by limiting the prescribing of drugs and monitoring their usage simultaneously. 

INSIGHTS BY END-USER 

Technology vendors accounted for a substantial share of 72% in 2020. 

The interest in digital health and related technologies increased rapidly in clinical medicine as well as biomedical research and drug discovery. Vendors are customizing their telehealth services by including e-prescribing. E-prescription integrated with advanced telehealth solutions can be used for routine check-ups or prescription refills. Some telehealth services are integrated with EHR to allow electronic prescription.

Pharmacies are increasingly utilizing ePrescribing solutions due to their several benefits. This allows pharmacies to stay competitive with larger chain pharmacies and reduce the time needed to process prescriptions. Pharmacy software incorporated with e-prescribing has turned into a game-changer for independent pharmacies that are planning to drive business improvements.

INSIGHTS BY GEOGRAPHY 

EU-5 countries accounted for more than 50% of the revenue share of the e-prescribing market in Europe.

In EU-5, a growing number of healthcare organizations are actively involved in the adoption of digitized services that include eHealth, telemedicine, e-prescribing, EHRs, and others. With such advancements, EU-5 is projected to grow at a lucrative rate due to the increasing demand for EHRs and online prescribing services, favourable governmental policies, and increasing healthcare expenditures.

The rest of Europe has considerable growth potential in the e-prescribing market due to ongoing government initiatives at the country level on implementing and mandating the use of electronic prescribing of medications. Other factors such as the prevalence of chronic illness, demand for online pharmacy & prescriptions, increased concerns of reducing medication errors, healthcare expenditures, and adoption of EHRs for telehealth services are boosting the use of electronic prescription in the region. 

EUROPE E-PRESCRIPTION MARKET COMPETITOR LANDSCAPE 

Surescripts, one of the leading e-prescribing solutions, accounted for more than 50% of the market share in 2020. 

The e-prescribing market in Europe consists of some prominent players, including Surescripts, Henry Schein, Aegis Healthcare, DrChrono, SISGAIN, CarePaths, eClinicalWorks, CGI, and Change Healthcare which contributing to the growth of the market in Europe. The market is likely to witness a rise and increased competition due to the emergence of mid-sized players and start-ups after the comprehensive implementation of online prescribing services across Europe. In coming years, European countries are likely to witness high growth as favourable government initiatives will mandate electronic prescribing software. 

The Europe e-prescribing market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments: 

Segmentation by Type

  • Standard
  • EPCS 

Segmentation by Delivery mode

  • Web & Cloud-based
  • On-Premise & Desktop 

Segmentation by Modality

  • Integrated
  • Standalone 

Segmentation by Medication

  • Cardiovascular
  • Anti-infectives
  • Oncology
  • Pain medication
  • Behavioral & Mental Health
  • Others 

Segmentation by End-users

  • Technology vendors
  • Independent & Specialty Pharmacies
  • Healthcare Facilities
  • PBM & Payors 

Segmentation by Geography

  • EU-5
    • UK
    • Italy
    • Spain
    • Germany
    • France
  • Rest of Europe
    • Netherlands
    • Sweden
    • Denmark
    • Austria
    • Finland
    • Other

Frequently Asked Questions

How big is the European e-prescribing market?

The Europe e-prescribing market size to cross over USD 1 billion by 2026.

What is the e-prescribing market growth rate?

The Europe e-prescribing market size to grow at a CAGR of around 23% during 2020-2026.

Who are the key players in the European e-prescribing market?

Surescripts, Henry Schein, Aegis Healthcare, DrChrono, Sisgain, Carepaths, Clinicalworks, and CGI are the key players in the Europe e-prescribing market.

Which segment accounted for the largest ePrescribing market share?

Web & cloud-based e-prescription accounted for a significant share and is likely to witness the highest incremental growth during the forecast period.

What are the key driving factors for the E-Prescribing Market?

Growing adoption of telehealth services in Europe, artificial intelligence to eradicate prescription error normalizing cross-border healthcare via new e-prescription paradigms, and favorable programs for high penetration of EHR are the key driving factors of the market

Download Free Sample

Europe e-prescribing market size is expected to grow at a CAGR of around 23% during 2020-2026 

The following factors are likely to contribute to the growth of the European e-prescription market during the forecast period: 

  • Growing adoption of telehealth services in Europe.
  • Artificial intelligence to eradicate prescription error normalizing cross-border healthcare via new e-prescription paradigms.
  • Favourable programs for high penetration of EHR.
  • Several European countries have passed laws and implemented policies for adopting e-prescription. 

Base Year:                 2020

Forecast Year:          2021–2026 

The report considers the present scenario of the Europe e-prescribing market and its market dynamics for the period 2021−2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market. 

Key Vendors

  • Surescripts
    • Business Overview
    • Business Segment
    • Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Henry Schein
  • Aegis Healthcare
  • DrChrono
  • SISGAIN
  • CarePaths
  • eClinicalworks
  • CGI
  • Change Healthcare

Other Prominent Vendors

  • Nortal
    • Business Overview
    • Product Offerings
  • Medicata

Segmentation by Type

  • Standard e-prescribing
  • EPCS 

Segmentation by Delivery mode

  • Web & Cloud based
  • On-premise & Desktop 

Segmentation by Modality

  • Integrated
  • Standalone 

Segmentation by Medication

  • Cardiovascular
  • Anti-infectives
  • Oncology
  • Pain medication
  • Behavioral & mental health
  • Others 

Segmentation by Geography

  • EU-5
    • UK
    • Italy
    • Spain
    • Germany
    • France
  • Rest of Europe
    • Netherlands
    • Sweden
    • Denmark
    • Austria
    • Finland
    • Other

1            Research Methodology

2            Research Objectives

3            Research Process

 

4            Scope & Coverage

4.1        Market Definition

4.1.1     Inclusions

4.1.2     Exclusions

4.1.3     Market Estimation Caveats

4.2        Base Year

4.3        Scope of The Study

4.3.1     Market Segmentation by Type

4.3.2     Market Segmentation by Delivery Mode

4.3.3     Market Segmentation by Modality

4.3.4     Market Segmentation by Medication Type

4.3.5     Market Segmentation by End-user

 

5            Report Assumptions & Caveats

5.1        Key Caveats

5.2        Currency Conversion

5.3        Market Derivation

 

6            Market at a Glance

7            Introduction

7.1        Overview

7.1.1     Features of an ideal e-prescribing system

7.1.2     Standards for Electronic Prescription Systems

7.1.3     State of E-prescribing in Europe

 

8            Market Opportunities & Trends

8.1        Growing Adoption of Telehealth Services In Europe

8.2        AI To Eradicate Prescription Errors

8.3        Normalizing Cross-Border Healthcare Via New E-Prescription Paradigms In Europe

 

9            Market Growth Enablers

9.1        Reducing Handwritten Prescriptions & Errors

9.2        Favorable Programs For High EHR Penetration

9.3        Initiatives For Adopting E-Prescribing In Europe

9.4        Healthcare Payors Influencing E-Prescribing Decisions

 

10         Market Restraints

10.1      Issues Regarding Security & Data Breach

10.2      Lack Of Standardization & Inadequate Training For Clinicians

10.3      Incompatible Software Systems & Complex Technologies

 

11         Market Landscape

11.1      Market Overview

11.2      Market Size & Forecast

11.3      Impact of COVID-19 in Europe

11.4      Five Forces Analysis

11.4.1   Threat of New Entrants

11.4.2   Bargaining Power of Suppliers

11.4.3   Bargaining Power of Buyers

11.4.4   Threat of Substitutes

11.4.5   Competitive Rivalry

 

12         Type

12.1      Market Snapshot & Growth Engine

12.2      Market Overview

12.3      Standard E-Prescribing

12.3.1   Market Overview

12.3.2   Market Size & Forecast

12.4      EPCS

12.4.1   Market Overview

12.4.2   Market Size & Forecast

 

13         Delivery Mode

13.1      Market Snapshot & Growth Engine

13.2      Market Overview

13.3      Web & Cloud-Based

13.3.1   Market Overview

13.3.2   Market Size & Forecast

13.4      On-Premise & Desktop

13.4.1   Market Overview

13.4.2   Market Size & Forecast

 

14         Modality

14.1      Market Snapshot & Growth Engine

14.2      Market Overview

14.3      Integrated

14.3.1   Market Overview

14.3.2   Market Size & Forecast

14.4      Standalone

14.4.1   Market Overview

14.4.2   Market Size & Forecast

 

15         Medication Type

15.1      Market Snapshot & Growth Engine

15.2      Market Overview

15.3      Cardiovascular

15.3.1   Market Overview

15.3.2   Market Size & Forecast

15.4      Anti-Infectives

15.4.1   Market Overview

15.4.2   Market Size & Forecast

15.5      Oncology

15.5.1   Market Overview

15.5.2   Market Size & Forecast

15.6      Pain Medication

15.6.1   Market Overview

15.6.2   Market Size & Forecast

15.7      Behavioral & Mental Health

15.7.1   Market Overview

15.7.2   Market Size & Forecast

15.8      Others

15.8.1   Market Overview

15.8.2   Market Size & Forecast

 

16         End-User

16.1      Market Snapshot & Growth Engine

16.2      Market Overview

16.3      Technology Vendors

16.3.1   Market Overview

16.3.2   Market Size & Forecast

16.4      Independent & Specialty Pharmacies

16.4.1   Market Overview

16.4.2   Market Size & Forecast

16.5      Healthcare Facilities

16.5.1   Market Overview

16.5.2   Market Size & Forecast

16.6      PBM & PAYORS

16.6.1   Market Overview

16.6.2   Market Size & Forecast

 

17         Geography

17.1      Market Snapshot & Growth Engine

17.2      Geographic Overview

 

18         EU-5

18.1      Market Overview

18.2      Market Size & Forecast

18.3      Key Countries

18.3.1   UK: Market Size & Forecast

18.3.2   Italy: Market Size & Forecast

18.3.3   Spain: Market Size & Forecast

18.3.4   Germany: Market Size & Forecast

18.3.5   France: Market Size & Forecast

 

19         Rest of Europe

19.1      Market Overview

19.2      Market Size & Forecast

19.3      Key Countries

19.3.1   Netherlands: Market Size & Forecast

19.3.2   Sweden: Market Size & Forecast

19.3.3   Denmark: Market Size & Forecast

19.3.4   Austria: Market Size & Forecast

19.3.5   Finland: Market Size & Forecast

19.3.6   Others: Market Size & Forecast

 

20         Competitive Landscape

20.1      Competition Overview

20.2      Market Share Analysis

20.2.1   Surescripts

20.2.2   Henry Schein

20.2.3   Aegis Healthcare

20.2.4   DrChrono

20.2.5   SISGAIN

20.2.6   CarePaths

20.2.7   eClinicalWorks

20.2.8   CGI

20.2.9   Change Healthcare

 

21         Key Company Profiles

21.1      Surescripts

21.1.1   Business Overview

21.1.2   Surescripts in E-prescribing Market

21.1.3   Product Offerings

21.1.4   Key Strategies

21.1.5   Key Strengths

21.1.6   Key Opportunities

21.2      Henry Schein

21.2.1   Business Overview

21.2.2   Henry Schein In E-Prescribing Market

21.2.3   Product Offerings

21.2.4   Key Strategies

21.2.5   Key Strengths

21.2.6   Key Opportunities

21.3      Aegis Healthcare

21.3.1   Business Overview

21.3.2   Aegis Healthcare in E-prescribing Market

21.3.3   Product Offerings

21.3.4   Key Strategies

21.3.5   Key Strengths

21.3.6   Key Opportunities

21.4      DrChrono

21.4.1   Business Overview

21.4.2   DrChrono in E-prescribing Market

21.4.3   Product Offerings

21.4.4   Key Strategies

21.4.5   Key Strengths

21.4.6   Key Opportunities

21.5      SISGAIN

21.5.1   Business Overview

21.5.2   SISGAIN in E-prescribing Market

21.5.3   Product Offerings

21.5.4   Key Strategies

21.5.5   Key Strengths

21.5.6   Key Opportunities

21.6      CarePaths

21.6.1   Business Overview

21.6.2   CarePaths in E-prescribing Market

21.6.3   Product Offerings

21.6.4   Key Strategies

21.6.5   Key Strengths

21.6.6   Key Opportunities

21.7      eClinicalWorks

21.7.1   Business Overview

21.7.2   eClinicalWorks in E-prescribing Market

21.7.3   Product Offerings

21.7.4   Key Strategies

21.7.5   Key Strengths

21.7.6   Key Opportunities

21.8      CGI

21.8.1   Business Overview

21.8.2   CGI in E-prescribing Market

21.8.3   Product Offerings

21.8.4   Key Strategies

21.8.5   Key Strengths

21.8.6   Key Opportunities

21.9      Change Healthcare

21.9.1   Business Overview

21.9.2   Change Healthcare in E-prescribing Market

21.9.3   Product Offerings

21.9.4   Key Strategies

21.9.5   Key Strengths

21.9.6   Key Opportunities

 

22         Other Prominent Vendors

22.1      Nortal

22.1.1   Business Overview

22.1.2   Product Offerings

22.2      Medicata

22.2.1   Business Overview

22.2.2   Product Offerings

 

23         Report Summary

23.1      Key Takeaways

23.2      Strategic Recommendations

 

24         Quantitative Summary

24.1      Market By Delivery Mode

24.2      Market By Type

24.3      Market By Modality

24.4      Market Medication Type

24.5      Market By End-User

 

25         Appendix

25.1      Abbreviations

 

List of Exhibits 

Exhibit 1             Segmentation of E-Prescribing Market in Europe

Exhibit 2             Market Size Calculation Approach 2020

Exhibit 3             Workflow Map of e-Prescribing Process in Pharmacies

Exhibit 4             Impact of Growing Adoption of Telehealth Services in Europe

Exhibit 5             Impact of AI to Eradicate Prescription Errors

Exhibit 6             Impact of Normalizing Cross-border Healthcare via New e-Prescription Paradigms in Europe

Exhibit 7             Impact of Reducing Handwritten Prescriptions & Errors

Exhibit 8             Impact of Favorable Programs for High EHR Penetration

Exhibit 9             Impact of Initiatives for Adopting e-Prescribing in Europe

Exhibit 10           Impact of Healthcare Payors Influencing e-Prescribing Decisions

Exhibit 11           Impact of Issues Regarding Security & Data Breach

Exhibit 12           Impact of Lack of Standardization & Inadequate Training for Clinicians

Exhibit 13           Impact of Incompatible Software Systems & Complex Technologies

Exhibit 14           E-prescribing Market in Europe 2020–2026 ($ million)

Exhibit 15           E-prescribing Market in Europe by Geography

Exhibit 16           E-prescribing Market in Europe by Type

Exhibit 17           E-prescribing Market in Europe by Delivery Mode

Exhibit 18           E-prescribing Market in Europe by Modality

Exhibit 19           E-prescribing Market in Europe by Medication Type

Exhibit 20           E-prescribing Market in Europe by End-user

Exhibit 21           COVID-19 Impact on Telemedicine Adoption in EU countries

Exhibit 22           Five Forces Analysis 2020

Exhibit 23           Incremental Growth by Type 2020 & 2026

Exhibit 24           E-prescribing Market in Europe by Type

Exhibit 25           E-prescribing Market in Europe by Type: Incremental Growth

Exhibit 26           E-prescribing Market in Europe by Type: Absolute Growth

Exhibit 27           Standard E-prescribing Market in Europe: Incremental & Absolute Growth

Exhibit 28           Standard E-prescribing Market in Europe 2020–2026 ($ million)

Exhibit 29           Non-medical Prescription Opioid Use in European Countries (2014)

Exhibit 30           EPCS Market in Europe: Incremental & Absolute Growth

Exhibit 31           EPCS Market in Europe 2020–2026 ($ million)

Exhibit 32           Incremental Growth by Delivery Mode 2020 & 2026

Exhibit 33           E-prescribing Market in Europe by Delivery Mode

Exhibit 34           E-prescribing Market in Europe by Delivery Mode: Incremental Growth

Exhibit 35           E-prescribing Market in Europe by Delivery Mode: Absolute Growth

Exhibit 36           Web & Cloud-based E-prescribing Market in Europe: Incremental & Absolute Growth

Exhibit 37           Web & Cloud-based E-prescribing Market in Europe 2020–2026 ($ million)

Exhibit 38           On-premise & Desktop E-prescribing Market in Europe: Incremental & Absolute Growth

Exhibit 39           On-Premise & Desktop E-prescribing Market in Europe 2020–2026 ($ million)

Exhibit 40           Incremental Growth by Modality 2020 & 2026

Exhibit 41           E-prescribing Market in Europe by Modality

Exhibit 42           E-prescribing Market in Europe by Modality: Incremental Growth

Exhibit 43           E-prescribing Market in Europe by Modality: Absolute Growth

Exhibit 44           Integrated E-prescribing Market in Europe: Incremental & Absolute Growth

Exhibit 45           Integrated E-prescribing Market in Europe 2020–2026 ($ million)

Exhibit 46           Standalone E-prescribing Market in Europe: Incremental & Absolute Growth

Exhibit 47           Standalone E-prescribing Market in Europe 2020–2026 ($ million)

Exhibit 48           Incremental Growth by Medication Type 2020 & 2026

Exhibit 49           E-prescribing Market in Europe by Medication Type

Exhibit 50           E-prescribing Market in Europe by Medication Type: Incremental Growth

Exhibit 51           E-prescribing Market in Europe by Medication Type: Absolute Growth

Exhibit 52           Cardiovascular E-prescribing Market in Europe: Incremental & Absolute Growth

Exhibit 53           Cardiovascular E-prescribing Market in Europe 2020–2026 ($ million)

Exhibit 54           Anti-infectives E-prescribing Market in Europe: Incremental & Absolute Growth

Exhibit 55           Anti-infectives E-prescribing Market in Europe 2020–2026 ($ million)

Exhibit 56           Oncology E-prescribing Market in Europe: Incremental & Absolute Growth

Exhibit 57           Oncology E-prescribing Market in Europe 2020–2026 ($ million)

Exhibit 58           Commonly Used Controlled Substances in Europe

Exhibit 59           Pain Medication E-prescribing Market in Europe: Incremental & Absolute Growth

Exhibit 60           Pain Medication E-prescribing Market in Europe 2020–2026 ($ million)

Exhibit 61           Behavioral & Mental Health E-prescribing Market in Europe: Incremental & Absolute Growth

Exhibit 62           Behavioral & Mental Health E-prescribing Market in Europe 2020–2026 ($ million)

Exhibit 63           Other E-prescribing Market in Europe: Incremental & Absolute Growth

Exhibit 64           Other E-prescribing Market in Europe 2020–2026 ($ million)

Exhibit 65           Incremental Growth by End-user 2020 & 2026

Exhibit 66           E-prescribing Market in Europe by End-User

Exhibit 67           E-prescribing Market in Europe by End-user: Incremental Growth

Exhibit 68           E-prescribing Market in Europe by End-user: Absolute Growth

Exhibit 69           E-prescribing Technology Vendors Market in Europe: Incremental & Absolute Growth

Exhibit 70           E-prescribing Technology Vendors Market in Europe 2020–2026 ($ million)

Exhibit 71           Number of Pharmacies in Major European Countries (2015)

Exhibit 72           E-prescribing Independent & Specialty Pharmacies Market in Europe: Incremental & Absolute Growth

Exhibit 73           E-prescribing Independent & Specialty Pharmacies Market in Europe 2020–2026 ($ million)

Exhibit 74           Rate of e-Prescribing in Primary Healthcare Facilities in Europe (2002–2013)

Exhibit 75           E-prescribing Healthcare Facilities Market in Europe: Incremental & Absolute Growth

Exhibit 76           E-prescribing Healthcare Facilities Market in Europe 2020–2026 ($ million)

Exhibit 77           E-prescribing PBM & Payors Market in Europe: Incremental & Absolute Growth

Exhibit 78           E-prescribing PBM & Payors Market in Europe 2020–2026 ($ million)

Exhibit 79           Incremental Growth by Geography 2020 & 2026

Exhibit 80           E-prescribing Market in Europe by Geography

Exhibit 81           E-prescribing Market in Europe by Geography: Incremental Growth

Exhibit 82           E-prescribing Market in Europe by Geography: Absolute Growth

Exhibit 83           E-prescribing Market in EU-5: Key Countries

Exhibit 84           Market Share of Major Countries in EU-5

Exhibit 85           Growth of e-Prescribing in Primary Care in EU-5 Countries

Exhibit 86           E-prescribing Market in EU-5: Incremental & Absolute Growth

Exhibit 87           E-prescribing Market in EU-5 2020–2026 ($ million)

Exhibit 88           Incremental Growth in EU-5 2020 & 2026

Exhibit 89           E-prescribing Market in UK 2020–2026 ($ million)

Exhibit 90           E-prescribing Market in Italy 2020–2026 ($ million)

Exhibit 91           E-prescribing Market in Spain 2020–2026 ($ million)

Exhibit 92           E-prescribing Market in Germany 2020–2026 ($ million)

Exhibit 93           E-prescribing Market in France 2020–2026 ($ million)

Exhibit 94           Market Share of Major Countries in Rest of Europe (%)

Exhibit 95           Growth of e-Prescribing in Primary Care in Rest of Europe (%)

Exhibit 96           E-prescribing Market in Rest of Europe: Incremental & Absolute Growth

Exhibit 97           E-prescribing Market in Rest of Europe 2020–2026 ($ million)

Exhibit 98           Incremental Growth in Rest of Europe 2020 & 2026

Exhibit 99           E-prescribing Market in Netherlands 2020–2026 ($ million)

Exhibit 100        E-prescribing Market in Sweden 2020–2026 ($ million)

Exhibit 101        E-prescribing Market in Denmark 2020–2026 ($ million)

Exhibit 102        E-prescribing Market in Austria 2020–2026 ($ million)

Exhibit 103        E-prescribing Market in Finland 2020–2026 ($ million)

Exhibit 104        E-prescribing Market in Other European Countries 2020–2026 ($ million)

Exhibit 105        E-Prescribing Market in Europe: Vendors Market Share 2020

             

             

List of Tables    

Table 1               Key Caveats

Table 2               Currency Conversion 2013−2020

Table 3               Cross-border e-Prescription Services Available in EU

Table 4               Pros & Cons for Standalone & Integrated E-prescribing Solutions

Table 5               Surescripts: Major Product Offerings

Table 6               Henry Schein: Major Product Offerings

Table 7               Aegis Healthcare: Major Product Offerings

Table 8               DrChrono: Major Product Offerings

Table 9               SISGAIN: Major Product Offerings

Table 10             CarePaths: Major Product Offerings

Table 11             eClinicalWorks: Major Product Offerings

Table 12             CGI: Major Product Offerings

Table 13             Change Healthcare: Major Product Offerings

Table 14             Nortal: Major Product Offerings

Table 15             Medicata: Major Product Offerings

Table 16             E-Prescribing Market in Europe by Delivery Mode 2020−2026 ($ million)

Table 17             E-Prescribing Market in Europe by Delivery Mode 2020−2026 (%)

Table 18             E-Prescribing Market in Europe by Type 2020−2026 ($ million)

Table 19             E-Prescribing Market in Europe by Type 2020−2026 (%)

Table 20             E-Prescribing Market in Europe by Modality 2020−2026 ($ million)

Table 21             E-Prescribing Market in Europe by Modality 2020−2026 (%)

Table 22             E-Prescribing Market in Europe by Medication Type 2020−2026 ($ million)

Table 23             E-Prescribing Market in Europe by Medication Type 2020−2026 (%)

Table 24             E-Prescribing Market in Europe by End-user 2020−2026 ($ million)

Table 25             E-Prescribing Market in Europe by End-user 2020−2026 (%)

Select a license type that suits your business needs

single-user Single User Licence
$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$3995.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$4995.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date